Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:40 PM
Ignite Modification Date:
2025-12-24 @ 9:40 PM
NCT ID:
NCT05293132
Eligibility Criteria:
Inclusion Criteria:
Age \>18 years old.
* Males and females
* Confirmed diagnosis of sepsis according to the third sepsis definition which include documented or suspected infection, plus an acute change in total SOFA score ≥ 2 points
Exclusion Criteria:
* Pregnancy
* A severe moribund state
* An anticipated ICU stay of less than 24 hours.
* Patients with a history of hypersensitivity to montelukast or co enzyme Q10.
* Patients with systemic eosinophilia in the blood or vasculitis.
* Patients with neuropsychiatric diseases as hallucinations, depression or suicidal thoughts that put the patient at risk when participating in the study.
* Unable to receive enteral medications.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05293132
Study Brief:
Protocol Section:
NCT05293132